All News #Library
Sciences
Recursion And Exscientia Combine To Advance AI Drug Discovery
20 Nov 2024 //
GLOBENEWSWIRE
AI biotechs Exscientia and Recursion agree $688m merger
10 Aug 2024 //
PHARMAPHORUM
Exscientia Launches AWS AI-powered Platform to Advance Drug Discovery
10 Jul 2024 //
BUSINESSWIRE
Human trials for world`s first AI-designed immuno-oncology drug
09 Apr 2021 //
PHARMATIMES

Market Place
Sourcing Support